News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
67,228 Results
Type
Article (6929)
Company Profile (15)
Press Release (60284)
Multimedia
Podcasts (17)
Webinars (2)
Section
Business (17061)
Career Advice (83)
Deals (2802)
Drug Delivery (13)
Drug Development (14896)
Employer Resources (16)
FDA (2046)
Job Trends (2408)
News (35948)
Policy (5402)
Tag
Academia (400)
Accelerated approval (1)
Adcomms (3)
Allergies (8)
Alliances (5606)
ALS (5)
Alzheimer's disease (173)
Antibody-drug conjugate (ADC) (13)
Approvals (2066)
Artificial intelligence (16)
Autoimmune disease (3)
Automation (1)
Bankruptcy (29)
Best Places to Work (2233)
BIOSECURE Act (2)
Biosimilars (11)
Biotechnology (8)
Bladder cancer (12)
Brain cancer (3)
Breast cancer (33)
Cancer (291)
Cardiovascular disease (11)
Career advice (79)
Career pathing (1)
CAR-T (26)
Cell therapy (63)
Cervical cancer (5)
Clinical research (10702)
Collaboration (99)
Compensation (12)
Complete response letters (1)
COVID-19 (2076)
CRISPR (4)
C-suite (30)
Cystic fibrosis (10)
Data (326)
Depression (1)
Diabetes (14)
Diagnostics (410)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (9)
Drug shortages (4)
Duchenne muscular dystrophy (5)
Earnings (5921)
Editorial (13)
Employer branding (1)
Employer resources (14)
Events (8457)
Executive appointments (59)
FDA (2256)
Frontotemporal dementia (2)
Funding (76)
Gene editing (16)
Generative AI (2)
Gene therapy (40)
GLP-1 (86)
Government (1878)
Grass and pollen (2)
Guidances (6)
Healthcare (2240)
IgA nephropathy (2)
Immunology and inflammation (17)
Indications (3)
Infectious disease (2183)
Inflammatory bowel disease (38)
Inflation Reduction Act (2)
Influenza (45)
Intellectual property (10)
Interviews (8)
IPO (1205)
IRA (6)
Job creations (321)
Job search strategy (75)
Labor market (1)
Layoffs (82)
Legal (531)
Liver cancer (5)
Lung cancer (25)
Lymphoma (22)
Machine learning (1)
Management (9)
Manufacturing (52)
MASH (1)
Medical device (444)
Medtech (444)
Mergers & acquisitions (1646)
Metabolic disorders (45)
Multiple sclerosis (18)
Neurodegenerative disease (7)
Neuropsychiatric disorders (1)
Neuroscience (219)
NextGen: Class of 2025 (412)
Non-profit (367)
Now hiring (5)
Obesity (26)
Opinion (38)
Ovarian cancer (19)
Pain (6)
Pancreatic cancer (5)
Parkinson's disease (10)
Partnered (3)
Patents (30)
Patient recruitment (6)
Peanut (6)
People (4788)
Pharmaceutical (6)
Pharmacy benefit managers (3)
Phase I (3839)
Phase II (4632)
Phase III (3737)
Pipeline (168)
Policy (45)
Postmarket research (427)
Preclinical (1658)
Press Release (20)
Prostate cancer (7)
Psychedelics (4)
Radiopharmaceuticals (15)
Rare diseases (45)
Real estate (510)
Recruiting (6)
Regulatory (3555)
Reports (12)
Research institute (413)
Resumes & cover letters (3)
RNA editing (2)
RSV (49)
Schizophrenia (1)
Series A (9)
Series B (4)
Service/supplier (1)
Sickle cell disease (6)
Spinal muscular atrophy (7)
Sponsored (4)
Startups (323)
Stomach cancer (1)
Supply chain (13)
Tariffs (9)
The Weekly (16)
Vaccines (804)
Venture capitalists (4)
Weight loss (20)
Worklife (1)
Date
Today (20)
Last 7 days (102)
Last 30 days (271)
Last 365 days (3633)
2025 (1113)
2024 (3910)
2023 (4542)
2022 (7866)
2021 (8864)
2020 (7241)
2019 (3442)
2018 (2591)
2017 (2680)
2016 (2544)
2015 (3091)
2014 (2271)
2013 (1806)
2012 (2044)
2011 (2220)
2010 (2018)
Location
Africa (173)
Alabama (21)
Alaska (1)
Arizona (4)
Arkansas (1)
Asia (4576)
Australia (737)
California (454)
Canada (194)
China (47)
Colorado (19)
Connecticut (26)
Delaware (18)
Europe (11289)
Florida (74)
Georgia (41)
Idaho (3)
Illinois (25)
India (6)
Indiana (31)
Iowa (1)
Japan (26)
Kansas (9)
Kentucky (3)
Maine (2)
Maryland (294)
Massachusetts (433)
Michigan (13)
Minnesota (14)
Missouri (4)
Montana (8)
Nebraska (2)
Nevada (1)
New Hampshire (1)
New Jersey (347)
New Mexico (3)
New York (188)
North Carolina (73)
North Dakota (7)
Northern California (213)
Ohio (12)
Oregon (1)
Pennsylvania (170)
Puerto Rico (1)
Rhode Island (6)
South America (113)
South Carolina (1)
Southern California (171)
Tennessee (3)
Texas (57)
United States (2368)
Utah (8)
Virginia (15)
Washington D.C. (3)
Washington State (44)
Wisconsin (1)
67,228 Results for "rational vaccines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. Announce Collaboration to Develop Herpes Vaccines in China
Rational Vaccines and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. announced they have reached an agreement to jointly develop, manufacture, and commercialize live vaccines against herpes simplex viruses.
October 30, 2023
·
2 min read
Government
Kennedy Changes Tune on MMR Vaccine as Second Child Dies of Measles
Kennedy, a long-time opponent of vaccines, stated that the MMR vaccine is “the most effective way” to combat the measles outbreak, which has already claimed the lives of two children in the U.S.
April 7, 2025
·
2 min read
·
Tristan Manalac
Policy
RFK Jr. Eyes Changes to Vaccines Injury Surveillance System to Deduce ‘Culprit’
Kennedy is planning modifications to the Vaccines Adverse Event Reporting System to identify whether vaccines contribute to an unstated problem. The reporting system is at the heart of the departure of CBER head Peter Marks.
April 17, 2025
·
2 min read
·
Tristan Manalac
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and less affordable,” according to vaccine expert Paul Offit. It could also further complicate the picture for companies like Novavax.
May 1, 2025
·
3 min read
·
Heather McKenzie
Press Releases
VIVALDI BIOSCIENCES’ UNIVERSAL INFLUENZA VACCINE SHOWS POTENTIAL TO BLOCK VIRUS TRANSMSSION AND DISEASE SPREAD
Study Results to be Presented at World Vaccine Congress
April 17, 2025
·
1 min read
Editorial
RFK Jr. Is Driving a Wedge Into Already Polarized Vaccine Conversations
When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and Human Services secretary are bringing down the hammer. What happens when there is no middle ground?
May 1, 2025
·
7 min read
·
Jef Akst
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Vaccines
HHS Pulls Funding for GeoVax’s Next-Gen COVID-19 Vaccine
GeoVax was using its HHS contract to develop its next-generation multi-antigen COVID-19 vaccine, which is in Phase IIb development.
April 17, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Doctors Rally Behind Vaccines as Doubts, Misinformation Mount
A group of medical experts expressed concern about growing “disinformation” and “misinformation,” calling for adherence to recommended vaccine schedules.
March 20, 2025
·
2 min read
·
Tristan Manalac
Vaccines
HHS Unfreezes Vaxart’s COVID-19 Study, Resumes Funding as Headwinds Batter Vaccines Space
While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by various regulatory roadblocks.
April 29, 2025
·
2 min read
·
Tristan Manalac
1 of 6,723
Next
